172 related articles for article (PubMed ID: 8944042)
1. Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study.
Longacre TA; Egbert BM; Rouse RV
Am J Surg Pathol; 1996 Dec; 20(12):1489-500. PubMed ID: 8944042
[TBL] [Abstract][Full Text] [Related]
2. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.
Kucher C; Zhang PJ; Pasha T; Elenitsas R; Wu H; Ming ME; Elder DE; Xu X
Am J Dermatopathol; 2004 Dec; 26(6):452-7. PubMed ID: 15618925
[TBL] [Abstract][Full Text] [Related]
3. Actin-rich desmoplastic malignant melanoma: report of three cases.
Riccioni L; Di Tommaso L; Collina G
Am J Dermatopathol; 1999 Dec; 21(6):537-41. PubMed ID: 10608246
[TBL] [Abstract][Full Text] [Related]
4. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma.
Kanik AB; Yaar M; Bhawan J
J Cutan Pathol; 1996 Jun; 23(3):205-10. PubMed ID: 8793654
[TBL] [Abstract][Full Text] [Related]
5. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
[TBL] [Abstract][Full Text] [Related]
6. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
7. Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases.
Anstey A; Cerio R; Ramnarain N; Orchard G; Smith N; Jones EW
Am J Dermatopathol; 1994 Feb; 16(1):14-22. PubMed ID: 7512798
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical and genetic profiles of melanomas with spindle cell morphology].
Heinstein VA; Ievleva AG; Imyanitov EN; Shelekhova KV
Arkh Patol; 2015; 77(4):17-23. PubMed ID: 26485776
[TBL] [Abstract][Full Text] [Related]
9. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.
Carlson JA; Dickersin GR; Sober AJ; Barnhill RL
Cancer; 1995 Jan; 75(2):478-94. PubMed ID: 7812919
[TBL] [Abstract][Full Text] [Related]
10. HMB45 negative spindle cell malignant melanoma.
Skelton HG; Maceira J; Smith KJ; McCarthy WF; Lupton GP; Graham JH
Am J Dermatopathol; 1997 Dec; 19(6):580-4. PubMed ID: 9415614
[TBL] [Abstract][Full Text] [Related]
11. [Desmoplastic malignant melanoma. Clinical and histopathologic results of a study in 34 patients].
Rütten A; Hügel H; Kutzner H; Schirren CG; Küchler A; Groth W
Hautarzt; 1996 Jun; 47(6):447-53. PubMed ID: 8767660
[TBL] [Abstract][Full Text] [Related]
12. Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases.
Romano RC; Carter JM; Folpe AL
Mod Pathol; 2015 Aug; 28(8):1033-42. PubMed ID: 26022451
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
Morgan MB; Purohit C; Anglin TR
Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
[TBL] [Abstract][Full Text] [Related]
14. [Unusual and unknown aspect of cutaneous malignant melanoma: minimal deviation malignant melanoma. Retrospective study of 45 cases].
Mérot Y; Mihm MC
Ann Dermatol Venereol; 1985; 112(4):325-36. PubMed ID: 4026131
[TBL] [Abstract][Full Text] [Related]
15. Desmoplastic malignant melanoma: diagnosis of early clinical lesions.
Wharton JM; Carlson JA; Mihm MC
Hum Pathol; 1999 May; 30(5):537-42. PubMed ID: 10333224
[TBL] [Abstract][Full Text] [Related]
16. NGFR-positive desmoplastic melanomas with focal or absent S-100 staining: Further evidence supporting the use of both NGFR and S-100 as a primary immunohistochemical panel for the diagnosis of desmoplastic melanomas.
Radfar A; Stefanato CM; Ghosn S; Bhawan J
Am J Dermatopathol; 2006 Apr; 28(2):162-7. PubMed ID: 16625082
[TBL] [Abstract][Full Text] [Related]
17. Desmoplastic malignant melanoma presenting with orbital involvement.
Ellis M; Drewe R; O'Day J
Aust N Z J Ophthalmol; 1994 May; 22(2):119-23. PubMed ID: 7917265
[TBL] [Abstract][Full Text] [Related]
18. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
19. Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma.
Harris GR; Shea CR; Horenstein MG; Reed JA; Burchette JL; Prieto VG
Am J Surg Pathol; 1999 Jul; 23(7):786-94. PubMed ID: 10403301
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the expression of vimentin and actin in spitz nevi and spitzoid malignant melanomas.
Alomari AK; Klump V; Neumeister V; Ariyan S; Narayan D; Lazova R
Am J Dermatopathol; 2015 Jan; 37(1):46-51. PubMed ID: 25548991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
